| Basics |
|
OmniAb, Inc.
|
| IPO Date: |
September 30, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$280.71M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 2.68%
|
| Avg Daily Range (30 D): |
$0.06 | 3.67%
|
| Avg Daily Range (90 D): |
$0.05 | 2.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.55M |
| Avg Daily Volume (30 D): |
.48M |
| Avg Daily Volume (90 D): |
.42M |
| Trade Size |
| Avg Trade Size (Sh.): |
117 |
| Avg Trade Size (Sh.) (30 D): |
148 |
| Avg Trade Size (Sh.) (90 D): |
136 |
| Institutional Trades |
| Total Inst.Trades: |
111 |
| Avg Inst. Trade: |
$1.53M |
| Avg Inst. Trade (30 D): |
$4.02M |
| Avg Inst. Trade (90 D): |
$1.7M |
| Avg Inst. Trade Volume: |
.52M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.58M |
| Avg Closing Trade (30 D): |
$.97M |
| Avg Closing Trade (90 D): |
$.88M |
| Avg Closing Volume: |
451.35K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.59
|
$-.14
|
$-.15
|
|
Diluted EPS
|
$-.59
|
$-.14
|
$-.15
|
|
Revenue
|
$ 21.09M
|
$ 2.24M
|
$ 3.9M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -63.67M
|
$ -16.53M
|
$ -15.88M
|
|
Operating Income / Loss
|
$ -69.08M
|
$ -18.14M
|
$ -16.22M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 1.3M
|
$ 10.26M
|
$ 7.39M
|
|
PE Ratio
|
|
|
|
|
|
|